Literature DB >> 18205011

Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity.

Yasar Sen1, Nurgun Kandemir, Ayfer Alikasifoglu, Nazli Gonc, Alev Ozon.   

Abstract

The present study was performed to determine the prevalence of metabolic syndrome (MS) and its risk factors in obese children and adolescents. The study included 352 obese children and adolescents (body mass index [BMI] > or = 95th percentile) aged between 2 and 19 years. The diagnosis of MS was made according to the criteria adapted from the World Health Organization (WHO) and the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines. BMI z-scores were calculated to assess the degree of obesity. The prevalence of MS and risk factors were determined. Determinants of MS were examined using regression analysis. The prevalence of MS was 41.8%. The age at onset of obesity, sedentary life-span, fasting blood levels of glucose, insulin, triglyceride, very-low-density lipoprotein (VLDL) cholesterol, and alanine aminotransferase (ALT) were higher, while levels of high-density lipoprotein (HDL) cholesterol and the number of actively spent hours were lower in cases with MS (p < 0.05). The most important determinant of MS was BMI z-score (r = 0.31, p < 0.0001). A one-point increase in BMI z-score yielded a 2-fold increase in the prevalence of MS. The prevalence of MS increased from 27.6% to 60.7% when the BMI z-score increased from 2.3 to 3.3. The risk of developing MS was 2.6-fold higher in cases with BMI z-score > 3 when compared to those with z-scores between 2 and 3. The results from this study indicate that, although the correlation between MS and the BMI z-score was weak, the BMI z-score may be an effective parameter in identifying obese children and adolescents at risk for MS. Screening the cases with BMI z-scores > or = 2 for MS is important for establishing an early diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18205011     DOI: 10.1007/s00431-007-0658-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  42 in total

Review 1.  The metabolic syndrome in children and adolescents.

Authors:  Martha L Cruz; Michael I Goran
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

2.  Prevalence of the insulin resistance syndrome in obesity.

Authors:  R M Viner; T Y Segal; E Lichtarowicz-Krynska; P Hindmarsh
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

3.  The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study.

Authors:  W Chen; S R Srinivasan; A Elkasabany; G S Berenson
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

Review 4.  Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.

Authors:  N Abate
Journal:  J Diabetes Complications       Date:  2000 May-Jun       Impact factor: 2.852

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.

Authors:  M Wabitsch; H Hauner; M Hertrampf; R Muche; B Hay; H Mayer; W Kratzer; K-M Debatin; E Heinze
Journal:  Int J Obes Relat Metab Disord       Date:  2004-02

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

9.  Indexes of insulin resistance and secretion in obese children and adolescents: a validation study.

Authors:  Louise S Conwell; Stewart G Trost; Wendy J Brown; Jennifer A Batch
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  25 in total

1.  Trends in the prevalence of extreme obesity among US preschool-aged children living in low-income families, 1998-2010.

Authors:  Liping Pan; Heidi M Blanck; Bettylou Sherry; Karen Dalenius; Laurence M Grummer-Strawn
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 2.  Cardiometabolic risk in obese children.

Authors:  Stephanie T Chung; Anthony U Onuzuruike; Sheela N Magge
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

3.  A longitudinal analysis of sugar-sweetened beverage intake in infancy and obesity at 6 years.

Authors:  Liping Pan; Ruowei Li; Sohyun Park; Deborah A Galuska; Bettylou Sherry; David S Freedman
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

4.  Prenatal exposure to airborne polycyclic aromatic hydrocarbons and childhood growth trajectories from age 5-14 years.

Authors:  Andrew G Rundle; Dympna Gallagher; Julie B Herbstman; Jeff Goldsmith; Darrell Holmes; Abeer Hassoun; Sharon Oberfield; Rachel L Miller; Howard Andrews; Elizabeth M Widen; Lori A Hoepner; Frederica Perera
Journal:  Environ Res       Date:  2019-07-19       Impact factor: 6.498

5.  The absence of insulin resistance in metabolic syndrome definition leads to underdiagnosing of metabolic risk in obese patients.

Authors:  Selim Kurtoglu; Leyla Akin; Mustafa Kendirci; Nihal Hatipoglu; Ferhan Elmali; Mümtaz Mazicioglu
Journal:  Eur J Pediatr       Date:  2012-03-28       Impact factor: 3.183

6.  Metabolic syndrome in young children: definitions and results of the IDEFICS study.

Authors:  W Ahrens; L A Moreno; S Mårild; D Molnár; A Siani; S De Henauw; J Böhmann; K Günther; C Hadjigeorgiou; L Iacoviello; L Lissner; T Veidebaum; H Pohlabeln; I Pigeot
Journal:  Int J Obes (Lond)       Date:  2014-09       Impact factor: 5.095

7.  Multidisciplinary therapy reduces risk factors for metabolic syndrome in obese adolescents.

Authors:  Josiane Aparecida Alves Bianchini; Danilo Fernandes da Silva; Claudia Christina Sanchez Nardo; Idalina Diair Regla Carolino; Florencio Hernandes; Nelson Nardo
Journal:  Eur J Pediatr       Date:  2012-10-25       Impact factor: 3.183

8.  Asthma symptom perception and obesity in children.

Authors:  Sheryl J Kopel; Natalie Walders-Abramson; Elizabeth L McQuaid; Ronald Seifer; Daphne Koinis-Mitchell; Robert B Klein; Marianne Z Wamboldt; Gregory K Fritz
Journal:  Biol Psychol       Date:  2009-11-24       Impact factor: 3.251

9.  Nitric oxide and clustering of metabolic syndrome components in pediatrics.

Authors:  Asghar Ghasemi; Saleh Zahediasl; Fereidoun Azizi
Journal:  Eur J Epidemiol       Date:  2009-08-22       Impact factor: 8.082

10.  Comparison of two classifications of metabolic syndrome in the pediatric population and the impact of cholesterol.

Authors:  F Prodam; R Ricotti; G Genoni; S Parlamento; A Petri; C Balossini; S Savastio; G Bona; S Bellone
Journal:  J Endocrinol Invest       Date:  2012-11-27       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.